Loading...
Elicio Therapeutics, Inc.
ELTX•NASDAQ
HealthcareBiotechnology
$7.83
$0.36(4.82%)
Elicio Therapeutics, Inc. (ELTX) Financial Performance & Statements
Review Elicio Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-25.85%
↓ 25.85%
Net Income Growth
-47.46%
↓ 47.46%
Operating Cash Flow Growth
-13.38%
↓ 13.38%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
890.05%
↑ 890.05%
ROIC
-271.83%
↓ 271.83%
Elicio Therapeutics, Inc. (ELTX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Elicio Therapeutics, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $1.17M | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $583000.00 | $0.00 | $293000.00 |
| Gross Profit | $0.00 | $583000.00 | $0.00 | -$293000.00 |
| Gross Profit Ratio | $0.00 | $0.50 | ||
| R&D Expenses | $7.78M | $10.71M | $7.21M | $8.18M |
| SG&A Expenses | $2.96M | $2.77M | $3.14M | $2.74M |
| Operating Expenses | $10.74M | $13.48M | $10.34M | $10.92M |
| Total Costs & Expenses | $0.00 | $14.06M | $10.34M | $10.92M |
| Interest Income | $210000.00 | $305000.00 | $185000.00 | $137000.00 |
| Interest Expense | -$176000.00 | $234000.00 | $137000.00 | $49000.00 |
| Depreciation & Amortization | $0.00 | $305000.00 | $290000.00 | $293000.00 |
| EBITDA | -$10.74M | -$13.46M | -$10.34M | -$6.89M |
| EBITDA Ratio | -$11.55 | |||
| Operating Income | -$10.74M | -$13.48M | -$10.34M | -$10.92M |
| Operating Income Ratio | -$11.56 | |||
| Other Income/Expenses (Net) | -$473000.00 | -$527000.00 | -$8.49M | $3.69M |
| Income Before Tax | -$11.21M | -$14.004M | -$18.84M | -$7.23M |
| Income Before Tax Ratio | -$12.01 | |||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$11.21M | -$14.004M | -$18.84M | -$7.23M |
| Net Income Ratio | -$12.01 | |||
| EPS | -$0.87 | -$1.15 | -$1.39 | -$0.64 |
| Diluted EPS | -$0.87 | -$1.15 | -$1.39 | -$0.64 |
| Weighted Avg Shares Outstanding | $12.95M | $12.20M | $13.58M | $11.28M |
| Weighted Avg Shares Outstanding (Diluted) | $12.95M | $12.20M | $13.58M | $11.28M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan